Myeloid ACE2 protects against septic hypotension and vascular dysfunction through Ang-(1-7)-Mas-mediated macrophage polarization

Redox Biol. 2024 Feb:69:103004. doi: 10.1016/j.redox.2023.103004. Epub 2023 Dec 18.

Abstract

Angiotensin converting enzyme 2 (ACE2) is a new identified member of the renin-angiotensin-aldosterone system (RAAS) that cleaves angiotensin II (Ang II) to Ang (1-7), which exerts anti-inflammatory and antioxidative activities via binding with Mas receptor (MasR). However, the functional role of ACE2 in sepsis-related hypotension remains unknown. Our results indicated that sepsis significantly reduced blood pressure and led to disruption between ACE-Ang II and ACE2-Ang (1-7) balance. ACE2 knock-in mice exhibited improved sepsis-induced mortality, hypotension and vascular dysfunction, while ACE2 knockout mice exhibited the opposite effects. Bone marrow transplantation and in vitro experiments confirmed that myeloid ACE2 exerted a protective role by suppressing oxidative stress, NO production and macrophage polarization via the Ang (1-7)-MasR-NF-κB and STAT1 pathways. Thus, ACE2 on myeloid cells could protect against sepsis-mediated hypotension and vascular dysfunction, and upregulating ACE2 may represent a promising therapeutic option for septic patients with hypotension.

Keywords: ACE2; Hypotension; Macrophage polarization; Sepsis; Vascular dysfunction.

MeSH terms

  • Angiotensin II / pharmacology
  • Angiotensin-Converting Enzyme 2 / genetics
  • Animals
  • Humans
  • Hypotension* / etiology
  • Macrophages / metabolism
  • Mice
  • Peptide Fragments / pharmacology
  • Peptidyl-Dipeptidase A / genetics
  • Peptidyl-Dipeptidase A / metabolism
  • Proto-Oncogene Mas
  • Sepsis* / complications

Substances

  • Peptidyl-Dipeptidase A
  • Angiotensin-Converting Enzyme 2
  • Proto-Oncogene Mas
  • Angiotensin II
  • Peptide Fragments